Loss of myeloid cannabinoid CB1 receptor confers atheroprotection by reducing macrophage proliferation and immunometabolic reprogramming https://www.biorxiv.org/content/10.1101/2023.04.06.535832v1?med=mas
Loss of myeloid cannabinoid CB1 receptor confers atheroprotection by reducing macrophage proliferation and immunometabolic reprogramming https://www.biorxiv.org/content/10.1101/2023.04.06.535832v1?med=mas